Bortezomib and Hypotonia - a phase IV clinical study of FDA data

Summary:

Hypotonia is reported as a side effect among people who take Bortezomib (bortezomib), especially for people who are female, 50-59 old, have been taking the drug for 1 - 6 months also take Myozyme, and have Asthma.

The phase IV clinical study analyzes which people have Hypotonia when taking Bortezomib. It is created by eHealthMe based on reports of 30,902 people who have side effects when taking Bortezomib from the FDA, and is updated regularly.

What is Bortezomib?

Bortezomib has active ingredients of bortezomib. eHealthMe is studying from 30,912 Bortezomib users. Check the latest studies of Bortezomib.

What is Hypotonia?

Hypotonia (low muscle tone) is found to be associated with 830 drugs and 1,767 conditions by eHealthMe. Check the latest studies of Hypotonia.

On Jul, 20, 2026

30,902 people reported to have side effects when taking Bortezomib.
Among them, 14 people (0.05%) have Hypotonia.

Among these 14 people:

How long have people been on Bortezomib when they have Hypotonia? *

What is the gender of people who have Hypotonia when taking Bortezomib? *

female: 54.55 %
male: 45.45 %

What is the age of people who have Hypotonia when taking Bortezomib? *

What are other drugs people take besides Bortezomib? *

Myozyme: 6 people, 42.86%
Dexamethasone: 4 people, 28.57%
Furosemide: 3 people, 21.43%
Solu-Medrol: 3 people, 21.43%
Febuxostat: 3 people, 21.43%
Olmesartan Medoxomil: 3 people, 21.43%
Fluticasone Propionate: 3 people, 21.43%
Formoterol Fumarate: 3 people, 21.43%
Warfarin Sodium: 2 people, 14.29%
Ezetimibe: 2 people, 14.29%

What are other side effects people have besides Hypotonia? *

High Blood Pressure: 8 people, 57.14%
Blood Immunoglobulin A Decreased: 6 people, 42.86%
Heart Rate Increased: 6 people, 42.86%
Disease Progression: 6 people, 42.86%
Hyperthermia Malignant (disease passed down through families that causes a fast rise in body temperature (fever) and severe muscle contractions): 6 people, 42.86%
Hypogammaglobulinaemia (an abnormally low concentration of gamma globulin in the blood and increased risk of infection): 6 people, 42.86%
Chronic Respiratory Failure: 6 people, 42.86%
Hypopnea: 6 people, 42.86%
Metabolic Acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body): 6 people, 42.86%
Cardio-Respiratory Arrest (sudden dysfunction of heart and lungs): 6 people, 42.86%

What are the existing conditions these people have? *

Uraemic Pruritus (severe itching caused by excess nitrogenous waste products in the urine): 3 people, 21.43%
Lichenoid Keratosis (a skin disorder described by rapid growing, reddish to brown, benign (noncancerous) lesion on the skin): 3 people, 21.43%
Itching: 3 people, 21.43%
Haematological Malignancy (cancer that affect blood, bone marrow, and lymph nodes): 3 people, 21.43%
Atopy (a genetic disposition to develop an allergic reaction): 3 people, 21.43%
Asthma: 3 people, 21.43%
Multiple Myeloma (cancer of the plasma cells): 2 people, 14.29%
Monoclonal Gammopathy: 2 people, 14.29%
Acute Kidney Failure: 2 people, 14.29%
Gastric Ulcer (stomach ulcer): 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Bortezomib and have Hypotonia?

- Check whether Hypotonia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Bortezomib:

Bortezomib (30,912 reports)

Hypotonia treatments and more:

Hypotonia (14,614 reports)

Browse all side effects of Bortezomib:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hypotonia:

Hypotonia (830 drugs)

Browse all the conditions that are associated with Hypotonia:

Hypotonia (1,767 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on bortezomib (the active ingredients of Bortezomib) and Bortezomib (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.